How it’s going
Before Don't Die, I built in payments, founding Braintree Venmo. Excited for the next frontier with Stable and @paoloardoino
Before Don't Die, I built in payments, founding Braintree Venmo.
Excited for the next frontier with Stable and @paoloardoino
Nietzsche agrees with me on sleep ht @Grimezsz
Nietzsche agrees with me on sleep
ht @Grimezsz
@DanielvsBabylon bro why are you calling me satan when I'm telling you to go to bed on time
@will__mcevoy we do need new katechons
4/ Significance and caveats of the OpenAI-Retro approach Advantages to regenerative medicine: The discovery removes long-standing barriers to regenerative medicine by enabling a scalable, efficient, and safer supply of iPSCs for use in tissue, organ, and cell therapy
4/ Significance and caveats of the OpenAI-Retro approach
Advantages to regenerative medicine: The discovery removes long-standing barriers to regenerative medicine by enabling a scalable, efficient, and safer supply of iPSCs for use in tissue, organ, and cell therapy
2/ 1/ OpenAI × Retro: Breaking the Bottleneck To overcome these barriers, OpenAI built GPT-4b micro, a compact model derived from GPT-4o but specialized for protein design. Initialized from a scaled-down GPT-4o, GPT-4b micro was trained by blending protein sequences, structural
2/ 1/ OpenAI × Retro: Breaking the Bottleneck
To overcome these barriers, OpenAI built GPT-4b micro, a compact model derived from GPT-4o but specialized for protein design.
Initialized from a scaled-down GPT-4o, GPT-4b micro was trained by blending protein sequences, structural
3/ Key Results (AI-generated KLF4 and SOX2 vs. traditional OSKM Controls) Variant hit rate + Expert-driven design of OSKM: < 10% of engineered variants outperform wild-type. + GPT-4b micro: 30% of SOX2 and 50% of KLF4 variants outperformed wild-type. Pluripotency induction
3/ Key Results (AI-generated KLF4 and SOX2 vs. traditional OSKM Controls)
Variant hit rate + Expert-driven design of OSKM: < 10% of engineered variants outperform wild-type. + GPT-4b micro: 30% of SOX2 and 50% of KLF4 variants outperformed wild-type.
Pluripotency induction
0/ AI Redesigns the Engines of Cellular Reprogramming OpenAI and Retro Biosciences reported a landmark achievement: using a domain-specialized protein design model, GPT-4b micro, they created engineered reprogramming factors that deliver over 50× higher efficiency in generating
0/ AI Redesigns the Engines of Cellular Reprogramming
OpenAI and Retro Biosciences reported a landmark achievement: using a domain-specialized protein design model, GPT-4b micro, they created engineered reprogramming factors that deliver over 50× higher efficiency in generating